{{Infobox drug class
| Image = Tamoxifen2DACS.svg
| Alt = 
| Caption = [[諾瓦得士|諾瓦得士]]，一種{{tsl|en|nonsteroidal|非固醇類}}{{tsl|en|triphenylethylene|三苯乙烯}}雌激素抑制劑，可用於治療[[乳癌|乳癌]]。
| Width = 250px
| Synonyms = SERM
<!-- Class identifiers -->
| Use = [[乳癌|乳癌]]、[[不孕|不孕]]、[[骨質疏鬆症|骨質疏鬆症]]、[[萎缩性阴道炎|萎缩性阴道炎]]、[[性交疼痛|性交疼痛]]、{{tsl|en|hormonal contraceptive|激素類避孕藥|避孕藥}}、[[性腺功能低下症|雄性腺功能低下症]]、[[男性乳房发育症|男性乳房发育症]]、[[乳房疼痛|乳房疼痛]]等等
| ATC_prefix = L02BB
| Biological_target = {{tsl|en|Estrogen receptor|動情素受體}}
| Chemical_class = 
<!-- Clinical data -->
| Drugs.com = 
| Consumer_Reports = 
| medicinenet = 
| rxlist = 
<!-- External links -->
| MeshID = 
}}
{{medical}}
'''選擇性雌激素受體調節物'''（{{lang|en|Selective estrogen receptor modulators}}，簡稱'''SERMs'''） 為作用於{{tsl|en|Estrogen receptor|動情素受體}}的[[药物|药物]]<ref name="Riggs_2003">{{cite journal | vauthors = Riggs BL, Hartmann LC | title = Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice | journal = The New England Journal of Medicine | volume = 348 | issue = 7 | pages = 618–29 | date = Feb 2003 | pmid = 12584371 | doi = 10.1056/NEJMra022219 }}</ref>。此類藥物可以分為動情素受體[[激动剂|激动剂]]以及[[受体拮抗剂|受体拮抗剂]]，此類藥物對於不同器官具有不同效果，進而達到選擇性作用於特定器官的目的。

SERMs屬於競爭型[[部分激动剂|部分激动剂]]<ref name="CameronCameron2013">{{cite book | first1 = John L. | last1 = Cameron | first2 = Andrew M | last2 = Cameron | name-list-format = vanc | title = Current Surgical Therapy | url = https://books.google.com/books?id=QwYyAgAAQBAJ&pg=PA582|date=20 November 2013|publisher=Elsevier Health Sciences|isbn=978-0-323-22511-3|pages=582–}}</ref>。由於身體各器官對於[[內源|內源性]][[雌激素|雌激素]]的感受性不同，所以SERM可能在某個器官為激動劑，卻同時在另一個器官扮演受體拮抗劑的角色<ref name="Huang_Aslanian_2012">{{cite book | first1 = Xianhai | last1 = Huang | first2 = Robert G. | last2 = Aslanian | name-list-format = vanc | title = Case Studies in Modern Drug Discovery and Development|url=https://books.google.com/books?id=MvsSTJigQcMC&pg=PA392|date=19 April 2012|publisher=John Wiley & Sons|isbn=978-1-118-21967-6|pages=392–394}}</ref>。這與SERM對於身體不同組織受體的[[效能_(藥理學)|效能]]有關，高效能SERM如{{tsl|en|chlorotrianisene|三對甲氧苯氯乙烯}}在身體中就通常扮演激動劑的角色。反之，低效能SERM如{{tsl|en|ethamoxytriphetol|乙胺氧三苯醇}}就主要扮演拮抗劑的角色。而[[clomifene|clomifene]]和[[諾瓦得士|諾瓦得士]]等中效能藥物就可能在體內不同器官扮演不同角色。

== 參見 ==
*{{tsl|en|Timeline of cancer treatment development||Timeline of cancer treatment development}}
* {{tsl|en|Selective estrogen receptor degrader||Selective estrogen receptor degrader}}
* {{tsl|en|Selective receptor modulator||Selective receptor modulator}}
* {{tsl|en|Selective androgen receptor modulator||Selective androgen receptor modulator}}
* {{tsl|en|Selective progesterone receptor modulator||Selective progesterone receptor modulator}}
* {{tsl|en|Selective glucocorticoid receptor agonist||Selective glucocorticoid receptor agonist}}
* {{tsl|en|Estrogen deprivation therapy||Estrogen deprivation therapy}}

== 參考文獻 ==
{{Reflist|33em}}

== 外部連結 ==
* [https://web.archive.org/web/20061215035151/http://www.aacr.org/home/public--media/for-the-media/fact-sheets/cancer-concepts/serms.aspx AACR Cancer Concepts Factsheet on SERMs]
* [https://web.archive.org/web/20070611194336/http://www.nsabp.pitt.edu/STAR/Index.html STAR: a head-to-head comparison of tamoxifen and raloxifene as breast-cancer preventatives]
* [http://www.femarelle.com Femarelle official site]
* [http://www.evista.com Raloxifene (Evista) official site]

{{Estrogens}}
{{Estrogenics}}

{{tsl|en|Category:Hormonal antineoplastic drugs||Category:Hormonal antineoplastic drugs}}
{{tsl|en|Category:Progonadotropins||Category:Progonadotropins}}

[[Category:選擇性雌激素受體調節物|*]]